New Brain Scan Drug Approved for Cancer Patients
The FDA approved a new brain cancer imaging drug from Telix Pharmaceuticals, giving doctors a better way to see tumors.
Doctors can now use a special new drug to see brain tumors more clearly. This drug, called Pixclara, helps doctors find brain cancer. It is the first drug of its kind approved for this use. This is good news for patients fighting brain cancer.
Telix Pharmaceuticals makes Pixclara. The drug helps with something called a PET scan. A PET scan is a type of imaging test. It helps doctors see what is happening inside the body. Pixclara will show a type of brain tumor called glioma.
This approval comes after a wait. The FDA first said no to the drug more than a year ago. Now, after review, they have given it the green light. This shows the drug meets important safety and effectiveness rules.
For regular people, this means doctors have a new tool. They can get a better picture of brain cancer. This can help them make better treatment plans. It brings new hope for many patients and their families.
Source: FierceBiotech
More from Biotech
